← Back to patent-cliff list
CAS 4039-32-1
1,1,1-Trimethyl-N-(trimethylsilyl)silanamine lithium salt
Codes: (XIV)989842-1-b
Application context (from source-drug indications)
Plaque psoriasisMufemilastUlcerative colitisMufemilastBehçet's syndromeMufemilastPsoriasisMufemilastChronic obstructive pulmonary diseaseMufemilastAtopic dermatitisMufemilast
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Mufemilast | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine→3-Hydroxy-4-methoxybenzaldehyde→1-Iodoethane→(3-Ethoxy-4-methoxy-phenyl)-methanone→1,1,1-Trimethyl-N-(trimethylsilyl)silanamine lithium salt→1-(Methylsulfonyl)methane→1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonyl-N-trimethylsilylethanamine→1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.